Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04794621 · ClinicalTrials.gov registry record · NA

Electroceutical Dressing Technology (EDT) Against Wound Microbial Biofilm Infection

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
112
Enrollment target

NCT04794621 is a NA study that has completed, run by Indiana University. The registered enrollment target is 112 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04794621, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target

Study Summary

There are currently limited treatments available that show anti-biofilm efficacy for wound infection management Biofilms account for over 80% of infections and approximately 65% of nosocomial infections caused by microorganisms in the developed world involve biofilms. There clearly is a need for cost effective, highly stable, easily obtained biofilm targeted strategies for treatment of chronic wound biofilm infections. The information generated from this project has the potential of providing considerable benefits to wound care by determining the efficacy of EDT dressing in managing wound biofilm infection and efficacy in wound healing and closure. Such knowledge could help therapeutic strategies and could provide information for future clinical studies to further understanding -of EDT wound dressings.

Interventions

  • DEVICE Electroceutical Dressing Technology-EDThi
  • DEVICE Adding EDTlo (Procellera®) for 3 weeks after use of EDThi

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2021-06-03
Est. Completion 2023-07-07
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT04794621

The ClinicalTrials.gov registry entry for NCT04794621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Electroceutical Dressing Technology-EDThi is the first listed.

NCT04794621 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04794621 about?

NCT04794621 is a clinical study titled "Electroceutical Dressing Technology (EDT) Against Wound Microbial Biofilm Infection". There are currently limited treatments available that show anti-biofilm efficacy for wound infection management Biofilms account for over 80% of infections and approximately 65% of nosocomial infections caused by microorganisms in the developed world involve biofilms. There clearly is a need for cos...

What is the current status of trial NCT04794621?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2021-06-03. Estimated completion is 2023-07-07.

What interventions are being tested in trial NCT04794621?

The interventions under investigation include: Electroceutical Dressing Technology-EDThi (DEVICE), Adding EDTlo (Procellera®) for 3 weeks after use of EDThi (DEVICE).

Who is sponsoring clinical trial NCT04794621?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.